Drug intelligence / Profile preview

Xiaozheng Pill

Development stage
Phase 4
Lead developer
Lei Yun Shang
Administration
Oral
01

Overview

Xiaozheng Pill (消癥丸) is a Traditional Chinese Medicine (TCM) developed and manufactured by Lei Yun Shang. It is formulated to activate blood circulation, resolve blood stasis, and soften hard masses to dissipate them. Clinically, it is primarily indicated for the treatment of gynecological conditions associated with Qi stagnation and blood stasis, including uterine fibroids (leiomyoma), ovarian cysts, and hyperplasia of mammary glands (breast hyperplasia). The formulation typically consists of multiple herbal ingredients such as *Sparganium stoloniferum* (Sanleng), *Curcuma zedoaria* (Ezhu), and *Prunus persica* (Taoren), which are traditionally recognized for their anti-proliferative and stasis-resolving properties. It is an approved pharmaceutical product in China.

Brand names
Xiaozheng Pill
Other names
Xiaozheng Wan消癥丸
02

Targets

CASP3 (Caspase-3)EGFR (Epidermal growth factor receptor)ERBB2 (Erb-b2 receptor tyrosine kinase 2)ESR1 (ERα)IL-6 (Interleukin 6)JNK (Mitogen-activated protein kinase kinase kinase family)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Xiaozheng Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaozheng Pill.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call